Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Joyce Rico

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Investigative Dermatology|February 17, 2006
Irwin Freedberg and industryM Joyce Rico
Allergy and Asthma Proceedings|July 20, 2002
Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effectsM Joyce Rico, Ira Lawrence
Journal of the American Academy of Dermatology|July 16, 2005
Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointmentE Richard Stiehm, Robert L Roberts, Michael S Kaplan, et al.
Archives of Dermatology|January 23, 2008
Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgarisVictoria P Werth, David Fivenson, Amit G Pandya, et al.
Journal of the American Academy of Dermatology|September 25, 2002
Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infectionsAlan B Fleischer, Mark Ling, Lawrence Eichenfield, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitisJon M Hanifin, Amy S Paller, Lawrence Eichenfield, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patientsJohn Y M Koo, Alan B Fleischer, William Abramovits, et al.
Journal of the American Academy of Dermatology|April 29, 2005
Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studiesAmy S Paller, Mark Lebwohl, Alan B Fleischer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Investigative Dermatology|February 17, 2006
Irwin Freedberg and industryM Joyce Rico
Allergy and Asthma Proceedings|July 20, 2002
Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effectsM Joyce Rico, Ira Lawrence
Journal of the American Academy of Dermatology|July 16, 2005
Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointmentE Richard Stiehm, Robert L Roberts, Michael S Kaplan, et al.
Archives of Dermatology|January 23, 2008
Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgarisVictoria P Werth, David Fivenson, Amit G Pandya, et al.
Journal of the American Academy of Dermatology|September 25, 2002
Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infectionsAlan B Fleischer, Mark Ling, Lawrence Eichenfield, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitisJon M Hanifin, Amy S Paller, Lawrence Eichenfield, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patientsJohn Y M Koo, Alan B Fleischer, William Abramovits, et al.
Journal of the American Academy of Dermatology|April 29, 2005
Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studiesAmy S Paller, Mark Lebwohl, Alan B Fleischer, et al.
Pageof 1